Key regions: United Kingdom, Canada, Japan, Europe, China
The Dermatological Drugs market in Russia has been showing steady growth over the past few years.
Customer preferences: Russian consumers have been showing a growing interest in skincare and dermatological products. This is partly due to increasing awareness of the importance of skin health and also due to the influence of social media and beauty bloggers. Consumers are looking for products that are effective, affordable and easy to use.
Trends in the market: One major trend in the Dermatological Drugs market in Russia is the growing demand for natural and organic products. Consumers are becoming more conscious of the ingredients in their skincare products and are looking for products that are free from harmful chemicals. Another trend is the increasing popularity of cosmeceuticals, which are products that combine cosmetic and pharmaceutical properties. These products are seen as a more effective way to treat skin concerns such as aging, acne and hyperpigmentation.
Local special circumstances: Russia has a unique climate and geography, which can have an impact on the Dermatological Drugs market. The harsh winters and dry air can lead to skin problems such as dryness, flakiness and sensitivity. This means that there is a high demand for moisturizing and soothing products. Additionally, Russia has a large population of people with fair skin, who are more prone to skin damage and skin cancer. This means that there is a high demand for sun protection products.
Underlying macroeconomic factors: The Russian economy has been recovering slowly from the recession of 2014-2015, which had a negative impact on consumer spending. However, there are signs of growth in the economy, which is expected to lead to an increase in consumer spending on skincare and beauty products. Additionally, the Russian government has been implementing policies to support the growth of the pharmaceutical industry, which is expected to have a positive impact on the Dermatological Drugs market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
